Kos Biotechnology Partners is a global investment firm founded by Simos Simeonidis and Alex Tzoukas, with the goal of becoming a premier life sciences-focused investment manager, providing superior returns and minimizing the risks inherent in the sector, while investing in tomorrow’s therapeutic breakthroughs.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.